Evidence map›Paper›PMID 41951917›Full record

ArticleEMBO molecular medicine2026

Fair priority setting in gene-editing research: the accountability for reasonableness framework.

Marije J Smits, Manon van Daal, Marcel Verweij, Edward Nieuwenhuis, Sabine Fuchs, Karin R Jongsma

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marije J SmitsDepartment of Pediatrics, Division of Metabolic Disorders, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Manon van DaalDepartment of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. m.vandaal@umcutrecht.nl.ORCID http://orcid.org/0000-0003-1718-2827
Marcel VerweijEthics Institute, Utrecht University, Janskerkhof 13a, Utrecht, 3512 BL, The Netherlands.
Edward NieuwenhuisPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Sabine Fuchs *Division of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
Karin R Jongsma *Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Funding

Koninklijke Nederlandse Akademie van Wetenschappen (KNAW) Ammodo Science Award 2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41951917
PMCPMC13179350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.